Log In
person
Celularity Inc
CELU
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2020
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| BioBanking |
Biomaterial Storage for Fertility Applications
These companies store biomaterial for fertility applications.
|
5.56M | 47.73% |
| Cell Therapy |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| Degenerative Diseases |
Biomaterials for Fertility Applications; private insurance
These companies manufacture biomaterial products for fertility applications. Their products are paid for primarily through private health insurance.
|
6.08M | 52.27% |
| keyboard_arrow_down |
BioBanking
Biomaterial Storage for Fertility Applications
|
5.56M | 47.73% |
| keyboard_arrow_right |
These companies store biomaterial for fertility applications.
|
||
| keyboard_arrow_down |
Cell Therapy
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Degenerative Diseases
Biomaterials for Fertility Applications; private insurance
|
6.08M | 52.27% |
| keyboard_arrow_right |
These companies manufacture biomaterial products for fertility applications. Their products are paid for primarily through private health insurance.
|
||